Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARO-INHBE in Obesity With and Without Type 2 Diabetes
NCT06700538Phase 2Active, not recruiting
- Sponsor
- Arrowhead Pharmaceuticals
- Start
- Dec 2024
- Primary completion
- Oct 2027
- Countries
- 4
01
Overview
A Phase 2 trial of ARO-INHBE in obesity, sponsored by Arrowhead Pharmaceuticals. Started Dec 2024; status: active, not recruiting.
02
Drugs
ARO-INHBE
03
Conditions
obesity
Beyond the preview
Go deeper on NCT06700538.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06700538.